CAS: 82248-59-7; Atomoxetine Hydrochloride

该化合物是一种选择性的无肾上腺素再摄入抑制剂,主要用于治疗注意力缺失多动性障碍(ADHD),其特点是化学配方,包括含氮芳香环和二生,有助于其药理活动,该物质通常以白粉和白晶状粉的形式呈现,在水和各种有机溶剂中溶解.亚托莫克辛盐盐盐在口服时表现出中到高的生物利用率,半衰期允许每天服一两次药.其行动机制包括抑制鼻血素转移器,导致合成骨裂体内无肾素含量增加,据信这可加强注意,减少对患有亚托克丁酸的病人的不耐性和高活性.该化合物一般地受到燃烧,但可能会造成副作用,如胃肠扰动,疲劳和情绪变化.与任何药物一样,在专业指导下,在对健康的潜在影响下,必须使用亚托克辛基盐酸盐的有害作用.

结构式图片

欧盟法规

C&L通报

上下游产品

(-)-N-tert-butoxycarbonyl-N-methyl-3-phenyl-3-(2-methylphenoxy)propanamine ortho-cresol (R)-N-methyl-3-phenyl-3-hydroxypropylamine -(-)-1-chloro-3-phenyl-3-(2-methylphenoxy)propane-(-)-1-chloro-3-phenyl-3-(2-methylphenoxy)propane(-)-N-tert-butoxycarbonyl-N-methyl-3-phenyl-3-(2-methylphenoxy)propanamine

合成工艺路线路线简述

  • 合成目标产物 Atomoxetine Hydrochloride 主要起始原料 2-Iodotoluene And (R)-(+)-3-(N-Methylamino)-1-Phenyl-1-Propanol
  • 83015-26-3 = 82248-59-7
    反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Diethyl Ether
    标题:Candida Rugosa Lipase-Catalyzed Kinetic Resolution Of β-Hydroxy-β-Arylpropionates And δ-Hydroxy-δ-Aryl-β-Oxo-Pentanoates
    作者:Xu,Chengfu; Et Al
    参考文献:Tetrahedron 日期:2005 卷标:61(8) 页码:2169-2186]

    63940-51-2 = 82248-59-7
    反应条件:1.1 Reagents: Sodium Hydroxide,(S)-Mandelic Acid Solvents: Water; 48 H,Rt1.2 Reagents: Sodium Hydroxide,Hydrochloric Acid Solvents: Ethyl Acetate,Water; Rt
    标题:New Technique For Synthesis Of Anti-Depression Drug Atomoxetine Hydrochloride
    作者:He,Xiaoqiang
    参考文献:Zhongguo Yaoxue Zazhi (Beijing 日期:2010 卷标:45(14) 页码:1104-1106]

    615-37-2 + 115290-81-8 = 82248-59-7
    反应条件:1.1 Reagents: Cesium Carbonate Catalysts: Cuprous Iodide Solvents: Xylene; 130 °C1.2 Reagents: Hydrochloric Acid Solvents: Isopropanol,Tert-Butyl Methyl Ether; 0 - 5 °C
    标题:Efficient Method For Preparing 3-Aryloxy-3-Arylpropylamines And Their Optical Stereoisomers
    参考文献:Canada]

    115290-81-8 = 82248-59-7 [标题:Reaction Conditions
    标题:A Site Isolation-Enabled Organocatalytic Approach To Enantiopure γ-Amino Alcohol Drugs
    作者:Wang,Shoulei; Et Al
    参考文献:Tetrahedron 日期:2018 卷标:74(29) 页码:3943-3946]

    100306-34-1 = 82248-59-7
    反应条件:1.1 Reagents: Triphenylphosphine,Diethyl Azodicarboxylate Solvents: Tetrahydrofuran; 24 H,20 °C2.1 Solvents: Ethanol,Water; 12 H,30 °C2.2 Reagents: Hydrochloric Acid Solvents: Water
    标题:The Synthesis Of Atomoxetine-Containing Carboxamides - Potential Human Carbonic Anhydrase Inhibitors
    作者:Shetnev,Anton A.; Et Al
    参考文献:American Chemical Science Journal 日期:2016 卷标:10(3) 页码:1-5]

    100306-34-1 = 82248-59-7
    反应条件:1.1 Reagents: Triphenylphosphine,Diethyl Azodicarboxylate Solvents: Tetrahydrofuran2.1 Solvents: Ethanol,Water2.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether
    标题:Chiral Synthesis Via Organoboranes. 18. Selective Reductions. 43. Diisopinocampheylchloroborane As An Excellent Chiral Reducing Reagent For The Synthesis Of Halo Alcohols Of High Enantiomeric Purity. A Highly Enantioselective Synthesis Of Both Optical Isomers Of Tomoxetine,Fluoxetine,And Nisoxetine
    作者:Srebnik,Morris; Et Al
    参考文献:Journal Of Organic Chemistry 日期:1988 卷标:53(13) 页码:2916-20]

    83015-26-3 = 82248-59-7
    反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Diethyl Ether
    标题:An Improved Method For The Synthesis Of Optically Active Tomoxetines And Fluoxetines
    作者:Xu,Cheng-Fu; Et Al
    参考文献:Chinese Journal Of Chemistry 日期:2004 卷标:22(8) 页码:775-778]

    114446-47-8 = 82248-59-7
    反应条件:1.1 Solvents: Ethanol,Water1.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether
    标题:Chiral Synthesis Via Organoboranes. 18. Selective Reductions. 43. Diisopinocampheylchloroborane As An Excellent Chiral Reducing Reagent For The Synthesis Of Halo Alcohols Of High Enantiomeric Purity. A Highly Enantioselective Synthesis Of Both Optical Isomers Of Tomoxetine,Fluoxetine,And Nisoxetine
    作者:Srebnik,Morris; Et Al
    参考文献:Journal Of Organic Chemistry 日期:1988 卷标:53(13) 页码:2916-20]

    114446-47-8 = 82248-59-7
    反应条件:1.1 Solvents: Water; 3 H,130 °C; 130 °C -> Rt1.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether,Water; Rt
    标题:A New Method For Synthesis Of Atomoxetine And Its Interaction With Azole-Containing Sulfonyl Chlorides
    作者:Korsakov,M. K.; Et Al
    参考文献:Zhurnal Organichnoi Ta Farmatsevtichnoi Khimii 日期:2013 卷标:11(4) 页码:38-41]

    114446-47-8 = 82248-59-7
    反应条件:1.1 Solvents: Ethanol,Water; 12 H,30 °C1.2 Reagents: Hydrochloric Acid Solvents: Water
    标题:The Synthesis Of Atomoxetine-Containing Carboxamides - Potential Human Carbonic Anhydrase Inhibitors
    作者:Shetnev,Anton A.; Et Al
    参考文献:American Chemical Science Journal 日期:2016 卷标:10(3) 页码:1-5]

    115290-79-4 = 82248-59-7
    反应条件:1.1 Solvents: Tetrahydrofuran
    标题:Asymmetric Synthesis Of Both Enantiomers Of Tomoxetine And Fluoxetine. Selective Reduction Of 2,3-Epoxycinnamyl Alcohol With Red-Al
    作者:Gao,Y.; Et Al
    参考文献:Journal Of Organic Chemistry 日期:1988 卷标:53(17) 页码:4081-4]

    115290-79-4 = 82248-59-7
    反应条件:1.1 Solvents: Tetrahydrofuran,Water; 3 H,65 °C1.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether; Rt
    标题:Regio- And Stereoselective Ring Opening Of Enantiomerically Enriched 2-Aryl Oxetanes And 2-Aryl Azetidines With Aryl Borates
    作者:Bertolini,Ferruccio; Et Al
    参考文献:Journal Of Organic Chemistry 日期:2008 卷标:73(22) 页码:8998-9007]

    134619-78-6 = 82248-59-7
    反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Ethanol
    标题:A New Chemoenzymic Enantioselective Synthesis Of R-(-)-Tomoxetine,(R)- And (S)-Fluoxetine
    作者:Kumar,Ashok; Et Al
    参考文献:Tetrahedron Letters 日期:1991 卷标:32(16) 页码:1901-4]

    114133-37-8 = 82248-59-7
    反应条件:1.1 Reagents: Triphenylphosphine,Diethyl Azodicarboxylate Solvents: Diethyl Ether; -10 °C -> 0 °C1.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether
    标题:Pd-Catalyzed Kinetic Resolution Of Benzylic Alcohols: A Practical Synthesis Of (R)-Tomoxetine And (S)-Fluoxetine Hydrochlorides
    作者:Ali,Iliyas Sayyed; Et Al
    参考文献:Tetrahedron Letters 日期:2002 卷标:43(31) 页码:5435-5436]

    100306-34-1 = 82248-59-7
    反应条件:1.1 Reagents: Triphenylphosphine,Diethyl Azodicarboxylate Solvents: Tetrahydrofuran; Rt; 14 H,Rt1.2 Solvents: Hexane; 30 Min,Reflux2.1 Solvents: Water; 3 H,130 °C; 130 °C -> Rt2.2 Reagents: Hydrochloric Acid Solvents: Diethyl Ether,Water; Rt
    标题:A New Method For Synthesis Of Atomoxetine And Its Interaction With Azole-Containing Sulfonyl Chlorides
    作者:Korsakov,M. K.; Et Al
    参考文献:Zhurnal Organichnoi Ta Farmatsevtichnoi Khimii 日期:2013 卷标:11(4) 页码:38-41
在 Potassium Carbonate,盐酸体系中,用 乙酸乙酯,异丙醇 作为反应溶剂,以72.6%的收率获得产物盐酸托莫西汀
参考文献:盐酸托莫西汀的制备
标题:盐酸托莫西汀的制备
摘要:本发明属于医药技术领域,具体涉及一种制备n‑甲基‑3‑苯氧基‑苯丙胺含量少于0.2%的盐酸托莫西汀的方法.盐酸托莫西汀是第一个用于治疗小儿多动症的非兴奋性药物,它是一种高度选择性去甲肾上腺素再摄取抑制剂,与其他神经递质亲和力极低,不会诱导抽动症状或增加运动障碍.n‑甲基‑3‑苯氧基‑苯丙胺是盐酸托莫西汀工艺杂质,因结构相似很难精制去除,根据欧洲药典规定n‑甲基‑3‑苯氧基‑苯丙胺含量不高于0.3,本发明能有效控制产品中n‑甲基‑3‑苯氧基‑苯丙胺含量,提高药品质量.

海关参考信息

专利信息


专利号:US-9353057-B2
优先权日:2003-12-30
标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
权利人:XENOPORT INC
摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

专利号:US-9315483-B2
优先权日:2007-09-13
标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof
发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT
权利人:CONCERT PHARMACEUTICALS INC
摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.

专利号:US-12180182-B2
优先权日:2021-12-01
标题 :(Di)amination of activated allene compounds, derivatives thereof, and methods for synthesis of the same
发明人:DAI MINGJI
权利人:PURDUE RESEARCH FOUNDATION
摘要:One-pot synthesis methods for producing amines from activated allenes and derivatives thereof are provided, as well as the compounds produced thereby.

专利号:US-10456387-B2
优先权日:2011-11-29
标 题:Phacetoperane for treating of attention deficit hyperactivity disorder
发明人:KONOFAL ERIC; FIGADERE BRUNO
权利人:NLS PHARMA AG; NLS PHARMACEUTICS AG
摘要:The invention relates to the treatment of an attention deficit hyperactivity disorder (ADHD) with alpha-phenyl(piperidin-2-yl)methanol, or the pharmaceutically acceptable salts and esters thereof, in particular the acetate derivative, more particularly dextrophacetoperane. The invention additionally provides a method of synthesis of the (S,S) enantiomer of alpha-phenyl(piperidin-2-yl)methanol as well as a method of synthesis of dextrophacetoperane.

专利号:US-7507861-B2
优先权日:2004-06-28
标题:Process for the preparation of atomoxetine hydrochloride
发明人:CASTELLI EUGENIO; LO MONACO GIUSEPPE; MANTOVANI SILVIA; DAVERIO PAOLA; RIVA PAOLO; VAILATI ALESSANDRA; BIANCHI STEFANO
权利人:TEVA PHARM FINE CHEMICALS SRL
摘要:The present invention provides improved processes for the preparation of atomoxetine hydrochloride under reaction conditions that improve reaction yields and facilitate commercial synthesis. In particular, the invention is directed to the synthesis of atomoxetine HCl by adding HCl to a mixture of (R)-(−)-tomoxetine (S)-(+)-mandelate with an organic solvent, with or without a base and water.

专利号:US-7576211-B2
优先权日:2004-09-30
标题 :Synthesis of thienopyridinone compounds and related intermediates
发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; CHEN DONGLI; MARANTZ YAEL; SHACHAM SHARON; HEIFETZ ALEXANDER; INBAL BOAZ; BAR-HAIM SHAY; MOHANTY PRADYUMNA; LOBERA MERCEDES; WU LAURENCE
权利人:EPIX DELAWARE INC
摘要:The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
苏州润森药物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.rosen-chemicals.com
企业联系电话:17712495068👤
📞苏州润森药物科技有限公司 ⚠️参考联系方式
联系人:杨总
电话:17712495068
手机:18751140360
传真:QQ:640192082
邮箱:sales@rosen-chemicals.com
通信地址: 江苏省苏州高新区新亭路5号1幢2楼
邮编: 235300
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省苏州高新区新亭路5号1幢2楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
广东利玮医药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.leawell.com.cn
电话: 020-8768-7760👤
📞广东利玮医药有限公司 ⚠️参考联系方式

销售电话:020-8768-7760
邮箱:enquiry@leawell.com.cn
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
浙江丽晶化学有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.regenchem.com
电话: 0576-88517095👤
📞浙江丽晶化学有限公司 ⚠️参考联系方式

销售电话:0576-88517095
邮箱:regen@regenchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海金洹化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jinhchem.com
企业联系电话:021-52210535👤
📞上海金洹化工有限公司 ⚠️参考联系方式
联系人:陈经理
电话:021-52210535
手机:13162045318
传真:021-67285091
邮箱:sales@jinhchem.com
通信地址: 上海市闵行区龙吴路5688弄89号202室
邮编: 200071
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市闵行区龙吴路5688弄89号202室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
盐城云涛化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.yuntao-chem.com
企业联系电话:0515-83090980;13512592619👤
📞盐城云涛化工有限公司 ⚠️参考联系方式
联系人:郭先生 13512592619
电话:0515-83090980;13512592619
手机:13512592619
传真:0515-83090980
邮箱:2838893166@qq.com
通信地址: 江苏省盐城市解放南路239号汇景大厦613室
邮编: 224011
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省盐城市解放南路239号汇景大厦613室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Handen BL, Aman MG, Arnold LE, Hyman SL, Tumuluru RV, Lecavalier L, Corbett-Dick P, Pan X, Hollway JA, Buchan-Page KA, Silverman LB, Brown NV, Rice RR Jr, Hellings J, Mruzek DW, McAuliffe-Bellin S, Hurt EA, Ryan MM, Levato L, Smith T. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2015 Nov;54(11):905-915. doi: 10.1016/j.jaac.2015.08.013. Epub 2015 Sep 3. doi: 10.1089/cap.2014.0178. Epub 2015 Oct 8. doi: 10.1002/phar.1635. doi: 10.1517/14656566.2015.1079620. doi: 10.1080/00325481.2015.1081046. doi: 10.1080/00325481.2015.1083394. Epub 2015 Sep 2. doi: 10.2217/PGS.15.93. Epub 2015 Aug 28. doi: 10.1089/cap.2015.0035. Epub 2015 Jul 29. doi: 10.1089/cap.2014.0155. Epub 2015 Jul 28.

合成参考文献


参考文献:10.1016/j.bbr.2010.02.020
摘要:Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C, Carboni E. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats. Behav Brain Res. 2010 Jun 26;210(1):99–106. doi: 10.1016/j.bbr.2010.02.020.
参考文献:10.1186/1745-6215-12-173
摘要:Hong SS, Cho SH. Acupuncture for attention deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial. Trials. 2011 Jul 11;12():173.
参考文献:10.1007/s00213-011-2393-2
摘要:Apostol G, Abi-Saab W, Kratochvil CJ, Adler LA, Robieson WZ, Gault LM, Pritchett YL, Feifel D, Collins MA, Saltarelli MD. Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology (Berl). 2012 Feb;219(3):715–25. doi: 10.1007/s00213-011-2393-2.
参考文献:10.1007/s11940-011-0137-6
摘要:Hirai N, Nishino S. Recent advances in the treatment of narcolepsy. Curr Treat Options Neurol. 2011 Oct;13(5):437–57. doi: 10.1007/s11940-011-0137-6.
参考文献:10.2147/ndt.s19613
摘要:Blier P, Briley M. The noradrenergic symptom cluster: clinical expression and neuropharmacology. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):15–20.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知